Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77836, first published .
Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies

Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies

Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies

Nana A Mensah   1 , MPH, PhD ;   Michael J Fassett   2, 3 , MD ;   Nehaa Khadka   1 , MPH, PhD ;   Jiaxiao M Shi   1 , PhD ;   Fagen Xie   1 , PhD ;   Vicki Y Chiu   1 , MS ;   Theresa M Im   1 , MPH ;   Sunhea Kim   1 , MPH ;   Daniella Park   1 , MPH ;   Carol Mao   4 , MS, MBA ;   Matthew Molaei   4 , MS, PharmD ;   Iris Lin   4 , PhD ;   Darios Getahun   1, 5 , MPH, MD, PhD

1 Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States

2 Department of Obstetrics & Gynecology, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, CA, United States

3 Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States

4 Johnson & Johnson, Horsham, PA, United States

5 Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States

Corresponding Author:

  • Darios Getahun, MPH, MD, PhD
  • Department of Research & Evaluation
  • Kaiser Permanente Southern California
  • 100 S Los Robles
  • Pasadena, CA 91101
  • United States
  • Phone: 1 626 564 5658
  • Fax: 1 626 564 3409
  • Email: Darios.T.Getahun@kp.org